NOS1 and Parkinson disease: Excessive nNOS-derived NO facilitates detrimental post-translational protein modifications that disrupt cellular biochemistry and compromise CNS functionality, with nNOS dysregulation being a recognized feature in PD progression (Maccallini and Amoroso, 2023).